Waters Corporation has introduced an AI-powered feature called Peak Integration, built into its widely used Empower software platform, aimed squarely at one of the most repetitive tasks in pharmaceutical manufacturing: manually reviewing chromatograms, the graphs scientists use to verify the chemical makeup of a drug compound.
The task Peak Integration targets sits inside quality assurance and quality control, the regulatory-driven process that pharmaceutical companies rely on to confirm that every batch of a medication matches its required chemical profile before it can be released. Historically, that has meant scientists manually reviewing hundreds of chromatograms by eye, flagging anything that deviates from the expected pattern, a process that is both essential for compliance and genuinely tedious to perform at scale.
Peak Integration automates that review using AI and machine learning, scanning large batches of chromatograms and identifying the ones that don’t match desired profiles without requiring a scientist to manually inspect each one. According to Waters, the tool cuts manual interventions by 95%, improves testing accuracy by 76%, and runs 50% faster than the process it replaces.
Those figures come out of an extended development process. Waters spent roughly 18 months collaborating with an undisclosed top-ten pharmaceutical company to build and train the underlying AI models, with much of that time going toward securing legal agreements and establishing secure data-exchange protocols rather than the modeling work itself, a reflection of how sensitive pharmaceutical manufacturing data is to share even for an internal efficiency tool.
Brook Colangelo, Waters' chief information officer, and David Leitham, vice president and general manager of the company's informatics software business, both pointed to the scale of Empower's footprint as part of why automating this specific task matters. The platform supports roughly 500,000 users globally and plays a role in releasing medications as varied as aspirin and Wegovy, meaning even a modest efficiency gain compounds significantly across the volume of drug batches that pass through quality control industry-wide.
For an industry where regulatory compliance leaves little room for error, the appeal of Peak Integration isn't just speed. Cutting manual interventions by 95% while improving accuracy suggests Waters is positioning the tool less as a shortcut and more as a way to reduce human error in a process where the margin for mistakes has always been thin.
